Vorinostat and bevacizumab for recurrent glioblastoma

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Vinay Puduvalli, Dr. Ying Yuan

Dr. Iyad Alnahhas interviews Drs. Vinay Puduvalli and Ying Yuan about their paper "A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma" published in Neuro-Oncology in March 2020

Episode metadata supplied by the publisher feed · Published Jan 1, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Vorinostat and bevacizumab for recurrent glioblastoma

0:00 32:52

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 32 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on January 1, 2021.

Can I download this Neuro-Oncology: The Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!